
Ductaclose 1mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Indomethacin (1mg)
Overview Ductaclose 1mg Injection
Injex 1mg provides relief from moderate pain and fever. It effectively manages pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis, gout, and ankylosing spondylitis, particularly when oral medication is unsuitable. Administration must be performed by a qualified healthcare provider; self-injection is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) should inform their physician. Report any injection site reactions (pain, swelling, redness) to your doctor immediately. Potential side effects include injection site reactions, bleeding disorders, nausea, vomiting, and abdominal pain. Dizziness, drowsiness, or visual disturbances may also occur. For extended treatment, regular monitoring of kidney and liver function, along with blood component levels, is recommended. Prolonged use carries a risk of severe complications, including gastrointestinal bleeding and renal impairment.
Uses of Ductaclose 1mg Injection
Analgesia
Major Benefits of Ductaclose 1mg Injection:
Administering this medication will be done by your physician or their assigned nurse; self-medication is strictly prohibited.
Common Side effects of Ductaclose 1mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Nausea
- Dizziness
- Visual disorder
- Drowsiness
- Bleeding disorder
- Increased creatinine level in blood
How to use Ductaclose 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ductaclose 1mg Injection works:
Celerin 1mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated swelling and redness.
SAFETY ADVICE
AlcoholCAUTION
Patients using Ductaclose 1mg Injection should avoid alcohol unless advised otherwise by their physician. Medical supervision is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Ductaclose 1mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
Administering Ductaclose 1mg Injection while breastfeeding carries a likely risk. Available human data indicates potential transfer to breast milk, posing a possible threat to the infant.
DrivingUNSAFE
Administration of Ductaclose 1mg Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Administering Ductaclose 1mg Injection requires careful consideration in individuals with advanced renal impairment. Dosage modification of Ductaclose 1mg Injection might be necessary. Physician consultation is recommended. Routine monitoring of renal function and serum potassium is advisable during treatment.
LiverCAUTION
Exercise caution when administering Ductaclose 1mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ductaclose 1mg Injection :
Omit a dose of Ductaclose 1mg Injection? Seek your physician's advice.
Facts to Know About Ductaclose 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Indazole-based Compounds |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
